Accelerbiotics ApS: Financial statements 2021
CVR: 40447148
Source: annual report 2021, Danish Business Authority
01/05/2020 – 30/04/2021
Accelerbiotics ApS (CVR 40447148) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 68,931 and a net result of DKK 53,699 compared with DKK -2,145 the year before. Equity in the 2021 report amounted to DKK 101,554. The solvency ratio was 87.5%.
- Gross Profit
- DKK 68,931
- Profit/Loss
- DKK 53,699
- Equity
- DKK 101,554
- Total Assets
- DKK 116,074
Official annual report
Find more companies like Accelerbiotics ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 21, 2021, Simo Abdessamad Baallal Jacobsen has stepped down as director of Accelerbiotics ApS.
Accelerbiotics ApS was dissolved on September 21, 2021.
About Accelerbiotics ApS
Accelerbiotics ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company has been dissolved on 21 September 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2020 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK 68,931 and a net result of DKK 53,699 compared with DKK -2,145 the year before. Equity in the 2021 report amounted to DKK 101,554.